Author | Study, continent | Age (years) | Subjects | Sex | Quality | Follow-up (years) | Outcome (cases) CVD | Method of measurement (vitamin D) |
---|---|---|---|---|---|---|---|---|
Lee, 2014 [39] | European Male Ageing Study (EMAS), Europe | 60 | 2452 | Male | High | 4.3 | 72 | Radioimmunoassay (RIA) |
Formiga, 2014 [40] | The Octabaix Study, Europe | 85 | 312 | Both | Moderate | 2.8 | 25 | Radioimmunoassay (RIA) |
Perna, 2013 [41] | ESTHER Study, Europe | 50–74 | 7709 | Both | High | 6.5 | 1011 | DiaSorin-Liason (Diasorin, Inc) and the IDS-iSYS (Immunodiagnostic Systems GmbH) immunoassayes |
Kühn, 2013 [42] | The European Investigation into Cancer and Nutrition (EPIC), Europe | 50.6 | 2132 | Both | High | 7.7 | 1030 | MassChrom reagent kit |
Scho¨ttker, 2013 [43] | ESTHER study, Europe | 50–74 | 9578 | Both | High | 9.5 | 350 | Diasorin-Liaison analyzer |
Bajaj, 2013 [44] | Osteoporotic Fractures in Men (MrOS), American | > 65 | 2990 | Male | Moderate | 5.9 | 740 | Liquid chromatography-tandem mass spectrometry |
Liu, 2012 [45] | Third National Health and Nutrition Examination Survey (NHANESIII), American | ≥ 35 | 13,134 | Both | Moderate | 8 | 1451 | Radioimmunoassay (RIA) |
Kritchevsky, 2012 [46] | the Health, Aging, and Body Composition study (Health ABC) study, American | 74.7 | 2638 | Both | High | 8.5 | 228 | Radioimmunoassay (RIA) |
Messenger, 2012 [47] | Osteoporotic Fractures in Men (MrOS) Study, American | 76.4 | 813 | Male | High | 4.4 | 140 | Mass spectrometry (MS) |
Welsh, 2012 [48] | The MIDSPAN Family Study, American | 30–59 | 1522 | Both | High | 14.4 | 297 | Mass spectrometry (MS) |
Kestenbaum, 2011 [49] | The CHS (Cardiovascular Health Study), American | ≥ 65 | 2312 | Both | High | 14 | 389 | Mass spectrometry (MS) |
Eaton, 2011 [50] | Women’s Health Initiative (WHI), American | 50–79 | 2429 | Female | High | 10 | 79 | Radioimmunoassay |
Anderson, 2010 [51] | Intermountain Heart Collaborative (IHC), American | 55 | 27,686 | Both | Moderate | 1.3 | 1193 | Chemiluminescent immunoassay |
Bolland, 2010 [18] | Healthy postmenopausal women, Others | 74 | 1471 | Female | High | 5 | 63 | Radioimmunoassay (RIA) |
Cawthon, 2010 [52] | Osteoporotic Fractures in Men (MrOS) study, American | ≥ 65 | 1594 | Male | High | 7.3 | 110 | Mass spectrometry (MS) |
Virtanen, 2010 [53] | The KIHD study, Europe | 53–73 | 1136 | Both | High | 9.1 | 35 | An HPLC using diode array detector |
Michae¨lsson, 2010 [54] | The Uppsala Longitudinal Study of Adult Men (ULSAM), Europe | 71 | 1194 | Male | High | 12.7 | 196 | Mass spectrometry (MS) |
Jassal, 2010 [21] | The Rancho Bernardo Study, American | 76 | 1073 | Both | High | 6.8 | 111 | Competitive binding protein recognition and chemiluminescence detection |
Hutchinson, 2010 [55] | the fourth Tromsø study, Europe | 58.9 | 7161 | Both | High | 11.7 | 325 | Immunometry (ECLIA) using an automated clinical chemistry analyzer |
Ginde, 2009 [56] | National Center for Health Statistics conducted the Third National Health and Nutrition Examination Survey (NHANES III), American | ≥ 65 | 3408 | Both | High | 7.3 | 767 | Radioimmunoassay (RIA) |
Pilz, 2009 [57] | The Hoorn Study Europe | 50–75 | 614 | Both | High | 6.2 | 20 | Means of a competitive binding protein assay |
Semba, 2009 [58] | Invecchiare in Chianti, “Aging in the Chianti Area” (InCHIANTI) study, Europe | ≥ 65 | 1006 | Both | Moderate | 6.5 | 107 | Radioimmunoassay (RIA) |
Dobnig, 2008 [19] | The Ludwigshafen Risk and Cardiovascular Health (LURIC) study, Europe | 62 | 737 | Both | Moderate | 7.7 | 463 | Radioimmunoassay (RIA) |
Melamed, 2008 [59] | Third NationalHealth and Nutrition Examination Survey (NHANESIII), American | ≥ 20 | 1331 | Both | Moderate | 8.7 | 777 | Radioimmunoassay (RIA) |
Wang, 2008 [60] | The Framingham Offspring cohort, American | 59 | 1739 | Both | High | 5.4 | 120 | Radioimmunoassay (RIA) |